IMF Videos Search Content For Healthcare Professional (132) Healthcare Provider (132) Care Partner (67) Patient (67) Series - Any - ASCO/EHA (51) ASH (69) Ask Dr. Durie (23) Black Swan Research Initiative (2) Emerging Therapies (3) Facebook Live (6) IMWG (4) Living Well with Myeloma (2) Myeloma in a Minute (5) Myeloma Made Simple (5) Myeloma University (4) Patient & Family Webinar (1) Q&A (11) Recent News and Developments (4) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (68) High-Risk Myeloma (45) High-risk Smoldering Myeloma (38) Late Relapse (4–6 Lines of Therapy) (84) MGUS (39) Newly Diagnosed (Pre-Treatment or First Treatment) (63) Smoldering Myeloma (49) Types of Therapy Immunomodulatory drugs (IMiDs) (60) Immunotherapies (CAR T; BiTE, etc.) (100) Monoclonal antibodies (54) Proteasome inhibitors (46) Stem cell transplant (38) Steroids (42) Supportive Care (43) Year Published 2026 (20) 2025 (32) 2024 (52) 2023 (43) 2022 (17) 2021 (12) 2020 (1) 2019 (10) 2018 (2) 2017 (1) 2016 (2) Trusted Voices Dr. Joseph Mikhael (36) Dr. Brian GM Durie (20) Dr. María-Victoria Mateos (7) Dr. Saad Usmani (3) Dr. Shaji Kumar (2) Dr. Sigurður Kristinsson (2) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (1) Donna Catamero, ANP-BC, OCN, CCRC (1) Dr. Sagar Lonial (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Will Myeloma Ever Be Curable? Answering Real Multiple Myeloma Patient Questions November 20, 2025 Q&A Your Myeloma Questions Answered: PET Scans, Side Effects, and New Treatment Options November 13, 2025 Q&A CAR T-cell Therapy & MRD Negativity in Myeloma: What Patients Need to Know September 25, 2025 Q&A Bispecific Antibodies Explained: How Bispecific Antibodies Use the Immune System September 18, 2025 Treatments Smoldering Myeloma vs. Double-Hit, Supplements & Nerve Effects | Top Myeloma Questions Answered August 21, 2025 Q&A Early Relapsed Multiple Myeloma: What’s Changing in 2025 | Research Breakthroughs from ASCO & EHA August 7, 2025 Emerging Therapies Key Abstracts Presented at ASCO and EHA 2025 August 1, 2025 ASCO/EHA Newly Diagnosed Multiple Myeloma: What’s Changing in 2025? | ASCO & EHA July 31, 2025 ASCO/EHA Linvoseltamab+Carfilzomib in Relapsed/Refractory Multiple Myeloma: LINKER-MM2 Trial Initial Results July 25, 2025 ASCO/EHA KRd with or without daratumumab in newly diagnosed multiple myeloma: ADVANCE trial results July 24, 2025 ASCO/EHA SC daratumumab + VRd with DR maintenance in TE NDMM: sustained MRD negativity in PERSEUS trial July 23, 2025 ASCO/EHA Subcutaneous vs IV isatuximab + pomalidomide/dexamethasone in R/R MM: IRAKLIA phase 3 study July 21, 2025 ASCO/EHA Load More
